Answer
Raloxifene hydrochloride should not be used in patients with signs or symptoms of endometrial cancer because its safety in this patient group has not been adequately studied.
Sources for this answer
- Raloxifene hydrochloride 60mg film-coated tabletsAspire Pharma Ltd · emc · SmPC §4.3 Contraindications · Version 1Document updated
Sources checked